U of M researchers discover protein that may be associated with better prognosis for women with ovarian cancer

Associate Professor, Martina Bazzaro, Ph.D., was recently featured in a University of Minnesota press release highlighting research into the GSL1 protein. A large amount of the GSL1 protein was thought to correlate with a gene mutation that occurs in up to 60% of clear cell ovarian cancer cases. However, investigators from the U of M Medical School and the Masonic Cancer Center (including Dr. Bazzaro) found evidence that challenges this idea and that indicates GLS1 instead has a protective benefit.

Read on here.

“This study provides an example of the utility of clinical tumor specimens from human patients for confirmation of preliminary results identifying potential drug targets,” said Martina Bazzaro, Ph.D.

Share this post

Related News